Amgen Kineret Needs Enbrel Combo Study And Combo Use Warning - Cmte

Labeling for Amgen's rheumatoid arthritis product Kineret (anakinra) should carry a strong warning against use with TNF-inhibitors, pending a double-blind safety trial studying combination use with Immunex' Enbrel (etanercept), FDA's Arthritis Advisory Committee recommended Aug. 16.